Tech Company Financing Transactions
Decibel Therapeutics Funding Round
Decibel Therapeutics closed a $24.3 million funding round on 1/16/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/16/2017
Transaction Type
Venture Equity
Amount
$24,332,584
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1325 Boylston St. 500
Boston, MA 02215
USA
Boston, MA 02215
USA
Phone
Website
Email Address
Overview
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurence Reid
Chief Financial Officer
Elisabeth Leiderman
Chief Scientific Officer
John Keilty
Chief Scientific Officer
John Lee
Vice President
Joseph Burns
Vice President
Adam Palermo
Vice President
Janeta Popovici-Muller
Vice President
Jonathon Whitton
Vice President
Heather Wolff
VP - Finance
Ronald Vigliotta
VP - Human Resources
Anna Trask
Browse more venture capital transactions:
Prev: 1/16/2017: SHINE Medical Technologies venture capital transaction
Next: 1/16/2017: Element Analytics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs